Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Antibody therapy in aggressive lymphomas.
Thomas M. Habermann
Hematology
Research output
:
Contribution to journal
›
Review article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antibody therapy in aggressive lymphomas.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Lymphoma
100%
Antibodies
66%
Vincristine
43%
Cyclophosphamide
37%
Doxorubicin
37%
Lymphoproliferative Disorders
31%
Prednisone
27%
Sialic Acid Binding Ig-like Lectin 2
24%
CD40 Antigens
23%
CD20 Antigens
21%
B-Lymphocytes
20%
Therapeutics
19%
Monoclonal Antibodies
19%
Radioimmunotherapy
18%
Immunoconjugates
17%
T-Lymphocytes
16%
Tumor Necrosis Factor Receptors
15%
Lymphoma, Large B-Cell, Diffuse
15%
Etoposide
14%
Natural History
13%
Non-Hodgkin's Lymphoma
12%
Dexamethasone
12%
Transplantation
10%
Stem Cells
9%
Transplants
8%